Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
59 studies found for:    parkinson's disease AND baylor
Show Display Options
Download search resultsDownload the search results for:
parkinson's disease AND baylor (59 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Unknown  MER Versus MRI Guidance DBS in Parkinson's Disease
Condition: Idiopathic Parkinson's Disease (PD)
Intervention:
2 Completed
Has Results
Amitiza in Constipation Associated With PD (Parkinson's Disease)
Condition: Parkinson's Disease
Intervention: Drug: LUBIPROSTONE
3 Completed Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD)
Condition: Parkinson Disease
Intervention: Drug: sodium oxybate
4 Completed Namenda (Memantine) for Non-Motor Symptoms in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Memantine;   Drug: placebo
5 Withdrawn Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: acamprosate
6 Completed Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Zelapar
7 Completed Parcopa Versus Carbidopa-Levodopa in a Single Dose Cross-Over Comparison Study
Condition: Parkinson's Disease
Interventions: Drug: Parcopa;   Drug: carbidopa-levodopa
8 Completed Flu-Like Symptoms as a Complication of Botulinum Toxin Therapy
Condition: Flu-like Symptoms
Intervention:
9 Completed Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations
Condition: Parkinson's Disease
Interventions: Drug: rasagiline mesylate;   Drug: 1.0 mg rasagiline mesylate;   Other: Placebo
10 Recruiting Study of Urate Elevation in Parkinson's Disease, Phase 3
Condition: Parkinson's Disease
Interventions: Drug: Inosine;   Drug: Placebo
11 Recruiting OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Conditions: Accidental Falls;   Fall Due to Loss of Equilibrium;   High Risk of Falls Due to Mobility Limitation;   Diabetes;   Arthritis;   Cancer;   Peripheral Arterial Disease;   Parkinson's Disease;   End Stage Renal Failure on Dialysis
Interventions: Device: AFO;   Other: Control
12 Recruiting SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
Condition: Parkinson's Disease Dementia (PDD)
Interventions: Drug: SYN120;   Drug: Placebo
13 Active, not recruiting Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes
Condition: Parkinson Disease
Intervention: Other: Virtual Visits
14 Completed Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)
Condition: Parkinson's Disease
Interventions: Drug: PYM50028;   Drug: Placebo
15 Recruiting Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
Condition: Parkinson Disease
Interventions: Drug: Placebo;   Drug: PF-06649751 low dose;   Drug: PF-06649751 middle dose level 1;   Drug: PF-06649751 middle dose level 2;   Drug: PF-06649751 high dose
16 Completed
Has Results
An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: IPX066
17 Completed
Has Results
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: placebo;   Drug: IPX066
18 Completed Parkinson's Research: The Organized Genetics Initiative
Condition: Parkinson Disease
Intervention:
19 Recruiting Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
Condition: Parkinson Disease
Intervention: Drug: Datscan and AV-133
20 Enrolling by invitation A Longitudinal Observational Follow-up of the PRECEPT Study Cohort
Condition: Parkinson Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.